Sort
78,016 grants matching “breast cancer”
INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER
$620,234Michael T Lewis · Baylor College Of Medicine · U24 · FY2022 · CA
INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER
$620,231Michael T Lewis · Baylor College Of Medicine · U24 · FY2023 · CA
Breast Cancer and the Environment Research Program Coordinating Center
$620,133Robert A Hiatt · University Of California, San Francisco · U01 · FY2012 · ES
Stem Cell Based Soft Tissue Reconstruction
$620,126Jeremy J. Mao · Columbia University Health Sciences · R01 · FY2009 · EB
ECM geometrical and mechanical properties modulate RTK signaling
$620,054Jay T. Groves · University Of California Berkeley · U01 · FY2019 · CA
CAREER: Modulating Local Tumor Hypoxia using Cryogel Scaffolds to Regulate Dendritic Cell Function and Activity
$620,046Sidi A Bencherif · Northeastern University · · FY2019 · MPS
ProstaFluor FDA Trial for Real-Time Margin Detection During Prostatectomy
$619,976David A. Benaron · Spectros Corporation · R01 · FY2011 · CA
Cook For Your Life: Maintaining diet and physical activity changes in Latina breast cancer survivors
$619,964Heather A Greenlee · Columbia University Health Sciences · R01 · FY2016 · CA
Programmable encapsulation systems to improve delivery of therapeutic bacteria
$619,930Tal Danino · Columbia Univ New York Morningside · R01 · FY2025 · EB
Handheld Spatial Frequency Domain Imaging using Spiral Illumination for Skin Imaging
$619,926Darren Michael Roblyer · Boston University (Charles River Campus) · R01 · FY2025 · EB
Obesity, chemotherapy dosing, and breast cancer outcomes
$619,893Elizabeth David Kantor · Sloan-Kettering Inst Can Research · R37 · FY2019 · CA
Quantitative volumetric ultrasonic and photoacoustic tomography
$619,842Katherine W Ferrara · Stanford University · R01 · FY2022 · CA
ACTIVATION OF ANTI-TUMORIGENIC STAT3BETA IN BREAST CANCER BY SPLICING REDIRECTION
$619,840Rutgers, The State University · · FY2012 · Department of Defense
Development of an ultrasound detectable, migration-resistant biopsy marker for improving care in patients with breast cancer
$619,809Matthew William Urban · Mayo Clinic Rochester · R01 · FY2025 · EB
Improving the platelet-mediated immune checkpoint inhibitor delivery for treating triple-negative breast cancer
$619,764Quanyin Hu · University Of Wisconsin-Madison · R01 · FY2025 · CA
The regulation of cancer and aging by methionine
$619,736Dudley William Lamming · University Of Wisconsin-Madison · R01 · FY2023 · AG
Predicting Breast Cancer Risk after Benign Percutaneous Biopsy
$619,727Mark E Sherman · Mayo Clinic Jacksonville · R01 · FY2019 · CA
Development of First-in-Class RIPK1 Degraders to Improve Cancer Immunotherapies
$619,714Jin Wang · Baylor College Of Medicine · R01 · FY2023 · CA
Longitudinal assessment of the role of interoception in chemotherapy-induced peripheral neuropathy (CIPN) along the cancer chemotherapy continuum
$619,710Ian Robert Kleckner · University Of Maryland Baltimore · R01 · FY2024 · CA
Targeting B7-H3 in ovarian cancer
$619,664Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
COPY NUMBER VARIANTS AND EARLY-ONSET BREAST CANCER
$619,638Paul Joseph Goodfellow · Ohio State University · R01 · FY2012 · CA
Development of TGF-beta antagonists for cancer therapy
$619,633Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Transcriptome-wide association study to identify susceptibility genes for colorectal cancer
$619,625Xingyi Guo · Vanderbilt University Medical Center · R37 · FY2018 · CA
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer
$619,610Gerald V Denis · Boston University Medical Campus · R01 · FY2021 · CA
Georgia CaRes
$619,518Sharad A. Ghamande · Augusta University · UG1 · FY2015 · CA